An analysis, conducted by the healthcare research company 3 Axis Advisors, said that Big Pharma corporations including Pfizer, AstraZeneca PLC, and Sanofi SA are set to raise the list prices—which do not include any rebates—on over 350 drugs early in January.
The pharmaceutical giants plan to raise U.S. prices for hundreds of drugs next month in anticipation of the Biden administration's Inflation Reduction Act, which will allow Medicare to negotiate the cost of certain drugs starting in 2026.
Pharma Giants to Hike 350+ US Drug Prices in the New Year: Analysis (commondreams.org)
No comments:
Post a Comment